Indevus Pharmaceuticals, Inc. http://www.alacrastore.com/company-snapshot/Indevus_Pharmaceuticals_Inc-1035543 Sunday, October 12, 2008 5:07:53 AM 1035543 Indevus Pharmaceuticals, Inc. en AlacraStore RSS Builder 1.0 30 http://www.alacrastore.com/storecontent/newstex/PRN-0005-28458902newstex/PRN-0005-28458902xml LEXINGTON, Mass., Sep. ##, #### (PRNewswire-FirstCall delivered by Newstex) -- Indevus Pharmaceuticals, Inc. (Nasdaq: IDEV) today announced the initiation of a Phase III clinical trial of the Company's novel octreotide implant for acromegaly....070000000700500004000000040020000400200604010000040100010701400007014012070030000700300107001000070010040200000002002000020020041300000013001000130010029/30/2008 9:25:32 AM180000001802000018018000PR Newswire USPRN-0005-28458902INDEVUS PHARMACEUTICALS INCGLENN L MD COOPERIDEVNewsNewstexhttp://www.alacrastore.com/storecontent/newstex/MCOM-0004-27695513newstex/MCOM-0004-27695513xml Aug. ##, #### (M# Communications Ltd. delivered by Newstex) -- Indevus Pharmaceuticals Inc (Nasdaq: IDEV) a specialty pharmaceutical company, said on ## August that it has completed a private placement of USD###.#m of non-recourse notes...04000000040020000400200604016000040160190700000007014000070140128/27/2008 6:21:00 AM1800000018013000M2 EquityBitesMCOM-0004-27695513ALLERGAN INCINDEVUS PHARMACEUTICALS INCAGNIDEVNewsNewstexhttp://www.alacrastore.com/storecontent/newstex/MCOM-0004-27404863newstex/MCOM-0004-27404863xml Aug. ##, #### (M# Communications Ltd. delivered by Newstex) -- Indevus Pharmaceuticals Inc (Nasdaq: IDEV), a specialty pharmaceutical company, declared on ## August the issuance of US Patent No. #,###,### (### patent), entitled "Once...040000000400200004002006040160000401603107000000070140000701401207003000070030011300000013010000130100058/14/2008 9:26:45 AM1800000018018000M2 EquityBitesMCOM-0004-27404863ALLERGAN INCINDEVUS PHARMACEUTICALS INCAGNIDEVNewsNewstexhttp://www.alacrastore.com/storecontent/newstex/PRN-0005-27386512newstex/PRN-0005-27386512xml LEXINGTON, Mass., Aug. ##, #### (PRNewswire-FirstCall delivered by Newstex) -- Indevus Pharmaceuticals, Inc. (Nasdaq: IDEV) announced today the issuance of U.S. Patent No. #,###,### (the "'### patent"), entitled "Once Daily Dosage Forms...040000000400200004002006040160000401603107000000070140000701401207003000070030010200000002002000020020081300000013010000130100058/13/2008 5:18:15 PM180000001801800018020000PR Newswire USPRN-0005-27386512ALLERGAN INCINDEVUS PHARMACEUTICALS INCMICHAEL W ROGERSAGNIDEVNewsNewstexhttp://www.alacrastore.com/storecontent/ccbn/T1896150ccbn/T1896150norm...Good day, ladies and gentlemen, and welcome to the Indevus Pharmaceuticals third quarter #### earnings conference call. I will be your coordinator for today. At this time, all participants are in listen-only mode, and we will be facilitating a question-and-answer session towards the end of this conference. (OPERATOR INSTRUCTIONS.) As a reminder, this conference is being recorded for replay purposes. I would now like to turn the presentation over to your host for today's call, Ms. Robin DeCarlo, Director of Corporate Communications and Investor Relations. Please proceed. ... 8/5/2008 10:06:00 AMIndevus Pharmaceuticals, Inc.106.0000FinalQ3 2008 Indevus Pharmaceuticals, Inc. Earnings Conference Call TranscriptIDEV9:00am ETTranscriptT1896150Credit & Investment ResearchThomson StreetEventshttp://www.alacrastore.com/storecontent/newstex/PRN-0005-27170653newstex/PRN-0005-27170653xml LEXINGTON, Mass., Aug. #, #### (PRNewswire-FirstCall delivered by Newstex) -- Indevus Pharmaceuticals, Inc. (Nasdaq: IDEV) today announced its consolidated results of operations for the third quarter ended June ##, ####. The Company...04000000040020000400200604016000040160480401600104016018040100000401000107000000070140000701401207003000070030011300000013010000130100058/5/2008 8:19:06 AM1800000018008000180040001802000018022000190000001900100019001018PR Newswire USPRN-0005-27170653INDEVUS PHARMACEUTICALS INCGLENN L MD COOPERMICHAEL W ROGERSIDEVNewsNewstexhttp://www.alacrastore.com/storecontent/newstex/PRN-0005-26997968newstex/PRN-0005-26997968xml LEXINGTON, Mass., Jul. ##, #### (PRNewswire-FirstCall delivered by Newstex) -- Indevus Pharmaceuticals, Inc. (Nasdaq: IDEV) will announce its third quarter #### financial results in a press release to be issued before market open on...0400000004002000040020060401600004016048040160180700000007014000070140121300000013010000130100057/29/2008 9:21:47 AM18000000180040001802000018008000PR Newswire USPRN-0005-26997968INDEVUS PHARMACEUTICALS INCMICHAEL W ROGERSIDEVNewsNewstexhttp://www.alacrastore.com/storecontent/ccbn/T1825155ccbn/T1825155norm...Good day, ladies and gentlemen, and welcome to the #### second quarter, Indevus Pharmaceuticals Incorporated earnings conference call. My name is Cynthia and I will be your operator for today's call. At this time, all participants under a listen-only mode. We will conduct a question-and-answer session towards the end of the conference. (OPERATOR INSTRUCTIONS) As a reminder this call is being recorded. I would now like to turn the call over to your host, Brooke Wagner, Vice President of Corporate Communications. ... 4/30/2008 10:05:00 AMIndevus Pharmaceuticals, Inc.54.0000FinalQ2 2008 Indevus Pharmaceuticals, Inc. Earnings Conference Call TranscriptIDEV9:00am ETTranscriptT1825155Credit & Investment ResearchThomson StreetEventshttp://www.alacrastore.com/storecontent/bir/212005bir/212005normIndevus Pharmaceuticals Inc.Valera Pharmaceuticals Inc.Interneuron Pharmaceuticals Inc.United StatesManufacturing: Pharmaceutical compounds.283432541217DGIDEV4/12/2008 6:14:00 AM212005Company Profiles & FinancialsGale Company Profileshttp://www.alacrastore.com/storecontent/ccbn/T1752091ccbn/T1752091normQ# #### Indevus Pharmaceuticals, Inc. Earnings Conference Call2/7/2008 10:09:00 AMIndevus Pharmaceuticals, Inc.54.0000FinalQ1 2008 Indevus Pharmaceuticals, Inc. Earnings Conference Call TranscriptIDEV9:00am ETTranscriptT1752091Credit & Investment ResearchThomson StreetEventshttp://www.alacrastore.com/storecontent/ccbn/T1702082ccbn/T1702082norm12/31/2007 5:21:23 PMIndevus Pharmaceuticals, Inc.54.0000FinalQ4 2007 Indevus Pharmaceuticals, Inc. Earnings Conference Call TranscriptIDEV9:00am ET...Good day, ladies and gentlemen and welcome to the fiscal #### year-end and fourth quarter earnings conference call. My name is Katie and I'll be your coordinator for today. At this time, all participants are in a listen-only mode. After the speaker remarks you will be invited to participate in a question-and-answer session. (OPERATOR INSTRUCTIONS). I would like to now turn the call over to your host for today, Mr. Brooke Wagner, Vice President of Corporate Communications. Please proceed, sir. ... TranscriptT1702082Credit & Investment ResearchThomson StreetEventshttp://www.alacrastore.com/storecontent/srp/23150srp/23150norm...Address:One Ledgemont Center, ## Hayden Avenue, Lexington, Massachusetts #####-#### Incorporated:DelawareWeb Site: www.indevus.comSIC Classification: Pharmaceutical Preparations (####) Business Description: Indevus Pharmaceuticals, Inc. is a biopharmaceutical company engaged in the acquisition, development and commercialization of a diversified portfolio of product candidates, including multiple compounds in late stage clinical development. Indices:Russell ####, Russell #### ... 23150454072109IDEV10/6/2006 12:38:00 PM23150Credit & Investment ResearchSharkRepellent.net